Accura and Legance have advised Impilo in connection with the transaction. Impilo, a leading Nordic investment firm exclusively focused on the healthcare sector, has acquired Oticon...
Impilo’s DKK600 Million Acquisition of Oticon Medical
Impilo Establishes EUR 320 Million Impilo Healthcare Fund
Vinge has advised Impilo. Impilo has established Impilo Healthcare, a private fund with EUR 320 million in commitments. The initiative marks a significant step for the...
Adven Sverige AB’s Acquisition of Österlens Kraft Fjärrvärme AB
Vinge advised Österlens Kraft economic association on the deal. Österlens Kraft economic association secured the sale of all shares in Österlens Kraft Fjärrvärme AB to Adven...
Impilo’s Establishment of a Continuation Fund
Vinge advised Impilo on the deal. Impilo secured the establishment of Impilo Orphan Drugs, a so-called continuation fund. The continuation fund will have EUR 320 million...
Scantox’s Acquisition of QPS Neuro
Accura acted as lead counsel to Scantox and Impilo in connection with the transaction. Scantox completed the acquisition of QPS’s Austrian neuropharmacology division. QPS Neuro is...
Impilo’s Acquisition of a Majority Stake in Decon
Stek advised Impilo on Decon acquisition. Impilo, a Nordic investment company specializing in sustainable healthcare investments in pharmaceuticals, medical technology, healthcare services, and related areas, has...